NASDAQ:ANAB | Free Cash Flow | ANAPTYSBIO, INC

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2015-12-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$25.92M$17,000.00-$25.94M
2025-12-31$98M$1,000.00$98M197.52%
2025-03-31-$10.7M$35,000.00-$10.74M
2024-12-31-$66.67M$263,000.00-$66.94M
2024-03-31-$37.25M$27,000.00-$37.28M
2023-12-31-$34.35M$280,000.00-$34.63M
2023-03-31-$24.57M$175,000.00-$24.74M
2022-12-31-$10.69M$175,000.00-$10.86M
2022-03-31-$21.01M$55,000.00-$21.07M
2021-12-31-$25.3M$14,000.00-$25.32M
2021-03-31-$23.2M$317,000.00-$23.52M
2020-12-31$37.58M$311,000.00$37.27M110.76%
2020-03-31-$15.11M$87,000.00-$15.2M
2019-12-31-$15.81M$104,000.00-$15.91M
2019-03-31-$16.1M$180,000.00-$16.28M
2018-12-31-$12.29M$206,000.00-$12.5M
2018-03-31-$12.48M$232,000.00-$12.71M
2017-12-31-$4.81M$124,000.00-$4.93M
2017-03-31-$8.1M$85,000.00-$8.18M
2016-12-31-$5.57M$1,000.00-$5.57M
2016-03-31-$2.06M$35,000.00-$2.09M

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31$19.7M$87,000.00$19.61M
2024-12-31-$135.34M$358,000.00-$135.7M
2023-12-31-$120.8M$807,000.00-$121.61M
2022-12-31-$73.59M$358,000.00-$73.95M
2021-12-31-$45.92M$1.37M-$47.29M
2020-12-31-$14.16M$569,000.00-$14.73M
2019-12-31-$69.52M$805,000.00-$70.32M
2018-12-31-$48.51M$1.06M-$49.57M
2017-12-31-$19.44M$290,000.00-$19.73M
2016-12-31-$9.03M$50,000.00-$9.08M
2015-12-31-$9.69M$238,000.00-$9.93M